Advertisement
UK markets close in 5 hours 59 minutes
  • FTSE 100

    7,869.48
    +21.49 (+0.27%)
     
  • FTSE 250

    19,423.73
    +83.59 (+0.43%)
     
  • AIM

    744.30
    +1.18 (+0.16%)
     
  • GBP/EUR

    1.1680
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2471
    +0.0015 (+0.12%)
     
  • Bitcoin GBP

    49,329.29
    -1,622.35 (-3.18%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CRUDE OIL

    82.01
    -0.68 (-0.82%)
     
  • GOLD FUTURES

    2,394.10
    +5.70 (+0.24%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • DAX

    17,785.17
    +15.15 (+0.09%)
     
  • CAC 40

    8,021.31
    +39.80 (+0.50%)
     

What Investors Need to Know About Jazz Pharmaceuticals' Planned Acquisition of GW Pharmaceuticals

In the first marijuana industry buyout of 2021, Jazz Pharmaceuticals (NASDAQ: JAZZ) agreed to pay a hefty $7.6 billion to acquire GW Pharmaceuticals (NASDAQ: GWPH), a developer of cannabis-based medications. Corinne Cardina: Another deal that was more recently announced just this week, Jazz Pharmaceuticals announced that they were going to be acquiring GW Pharmaceuticals.